teleABLE to Reduce Post-Stroke Sedentary Behavior
Running, not enrolling · Not applicable
Conditions studied: Stroke
In brief
The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months. Participants in this study will: * Complete questionnaires at Weeks 1, 8, and 24 * Wear an activPAL monitor at Weeks 1, 8, and 24 * Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions) * Complete an interview at Week 24
Key facts
- Study ID
- NCT06312709
- Run by
- University of Minnesota
- People needed
- 90
- Starts
- 2024-04-04
- Expected to finish
- 2026-08-30
- Last updated by the study team
- 2026-05-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age: 18 years or older
- Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment
- ≥6 hours of sedentary behavior on a typical weekday (Sedentary Behavior Questionnaire)
- Able to walk 150 feet or more without physical assistance from another person, with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5)
- Able to access an electronic device (smartphone, tablet, or computer) that is compatible with a videoconferencing application
- Able to identify a support person with whom they have a face-to-face interaction at least one time per week.
- Able and willing to participate fully in the study and provide informed consent
You may not qualify if…
- Currently receiving care in an inpatient rehabilitation, transitional care unit, or skilled nursing facility
- Severe cognitive or communication impairments (inability to respond accurately to complete study telephone screening or complete informed consent)
- Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma)
- Comorbid cancer, currently undergoing chemotherapy or radiation treatment
- Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2)
- Received inpatient treatment or hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
- Diagnosis of a terminal illness and/or currently receiving hospice care
- Currently pregnant or expecting to become pregnant in the next 6 months
- History of skin sensitivity that precludes the use of medical tape necessary for adherence to activity monitor measure
- Inability to speak, read, or understand English
- Concurrent participation in any other rehabilitation intervention research study (including cognitive and/or physical rehabilitation studies)
- Investigator discretion for safety or adherence reasons
Where it is running
- School of Kinesiology, University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.